Jackson; Philip Stephen
Patent Applications and Registrations
Patent applications and USPTO patent grants for Jackson; Philip Stephen.The latest application filed is for "use of nk-1 receptor antagonists for treating major depressive disorders".
- Jackson; Philip Stephen - Harlow GB
- Jackson; Philip Stephen - Basildon GB
- Jackson; Philip Stephen - Grantham GB
| Patent | Date |
|---|---|
| Use of NK-1 receptor antagonists for treating major depressive disorders Grant 6,613,765 - Baker , et al. September 2, 2 | 2003-09-02 |
| Spiro-azacyclic derivatives and their use as therapeutic agents Grant 6,172,077 - Curtis , et al. January 9, 2 | 2001-01-09 |
| Use of NK-1 receptor antagonists for treating major depressive disorders with anxiety Grant 6,114,315 - Baker , et al. September 5, 2 | 2000-09-05 |
| Spiro-piperidine derivatives and their use as therapeutic agents Grant 6,071,927 - Baker , et al. June 6, 2 | 2000-06-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 